Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, discusses the lessons that the field of cell and gene therapy can learn from the COVID-19 pandemic. The accelerated development and approval of vaccines for COVID-19 has demonstrated the positive impact of cross collaboration within the industry. The use of mRNA technology in vaccine development has also enhanced understanding and infrastructure, and these advances could be leveraged in the field of cell and gene therapy such as through the use of mRNA-based boosters for CAR T-cell therapies. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.